Search
Now showing items 1-10 of 42
Risk Factors for Acquisition of Endemic Blastomycosis
(2009-1-1)
BACKGROUND: Blastomycosis is potentially fatal, but environmental risk factors for acquiring blastomycosis are not well established.METHOD: Matched cross-sectional questionnaire of 112 patients with history of blastomycosis ...
Prevalence and Correlates of Pain in the Canadian National Palliative Care Survey
(2009-1-1)
BACKGROUND: Pain is a common problem for people with cancer who are nearing the ends of their lives.OBJECTIVE: In the present multicentre Canadian study of palliative cancer care, the prevalence of pain, its perceived ...
Comparison of Community-Associated and Health Care-Associated Methicillin-Resistant Staphylococcus aureus in Canada: Results from CANWARD 2007
(2009-1-1)
BACKGROUND: Community-associated methicillin-resistant
Staphylococcus aureus (CA-MRSA) differ from health care-associated
MRSA (HA-MRSA) in their genotypic and phenotypic characteristics.
The purpose of the present study ...
Prevalence and Characterization of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Isolated in Canadian Hospitals: Results from CANWARD 2007
(2009-1-1)
OBJECTIVE: The purpose of the present study was to determine the prevalence
and molecular epidemiology of extended-spectrum beta-lactamase
(ESBL)-producing Enterobacteriaceae identified from Canadian hospitals
in 2007.
METHODS: ...
In Vitro Activities of Ceftobiprole and Doripenem Tested against Frequently Encountered Aerobic and Facultative Gram-Positive and Gram-Negative Bacterial Pathogens Isolated from Patients in Canadian Hospitals in 2007
(2009-1-1)
BACKGROUND: In 2008, ceftobiprole was approved by Health
Canada for the treatment of patients with complicated skin and skin
structure infections including diabetic foot infections; approval of
ceftobiprole by the United ...
Prevalence of Antimicrobial-Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2007)
(2009-1-1)
BACKGROUND: Canadian hospitals as well as hospitals worldwide
are increasingly faced with antibiotic-resistant pathogens, including
multidrug-resistant (MDR) strains.
OBJECTIVES: To assess the prevalence of pathogens, ...
An Atypical Presentation of Liver Enzyme Elevation Resulting from Bosentan Use
(2009-1-1)
Hepatocellular enzyme elevation is a known side effect of both bosentan and atorvastatin. However, a rise in liver enzyme level not characteristic of either agent individually may represent a reaction to their combination ...
Mutant Prevention Concentrations of Doripenem and Meropenem Alone and in Combination with Colistin (Polymyxin E), Levofloxacin and Tobramycin in Pseudomonas aeruginosa
(2009-1-1)
BACKGROUND: With a limited number of available antimicrobial
agents to treat Pseudomonas aeruginosa infections, the prevention of
emergence of antimicrobial resistance and its subsequent spread is
critical. In the present ...
Antimicrobial Susceptibility of 6685 Organisms Isolated from Canadian Hospitals: CANWARD 2007
(2009-1-1)
BACKGROUND: Antimicrobial resistance is a growing problem in
North American hospitals as well as hospitals worldwide.
OBJECTIVES: To assess the antimicrobial susceptibility patterns of
commonly used agents against the 20 ...
Comparison of Per Cent Predicted and Percentile Values for Pulmonary Function Test Interpretation
(2009-1-1)
BACKGROUND: Pulmonary function tests (PFTs) are commonly interpreted as a fraction of predicted normal values, with an abnormal test often defined as less than 80% or greater than 120% of the predicted value. However, ...